KLRS FY 2024 Earnings — Kalaris Therapeutics Inc Revenue & Financial Results | Market Cap Arena

KLRSKalaris Therapeutics Inc

$187M

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$55M

Net Income

-$59M

EPS (Diluted)

$-11.73

Cash Flow

Operating Cash Flow

-$68M

Free Cash Flow

-$68M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$119M

Total Liabilities

$5M

Stockholders' Equity

$113M

Cash & Equivalents

$118M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$55M	-$13M	-310.4%
Net Income	-$59M	-$15M	-299.8%